Literature DB >> 25079666

Primary culture of human vestibular schwannomas.

Nathan M Schularick1, J Jason Clark1, Marlan R Hansen2.   

Abstract

Vestibular schwannomas (VSs) represent Schwann cell (SC) tumors of the vestibular nerve, compromising 10% of all intracranial neoplasms. VSs occur in either sporadic or familial (neurofibromatosis type 2, NF2) forms, both associated with inactivating defects in the NF2 tumor suppressor gene. Treatment for VSs is generally surgical resection or radiosurgery, however the morbidity of such procedures has driven investigations into less invasive treatments. Historically, lack of access to fresh tissue specimens and the fact that schwannoma cells are not immortalized have significantly hampered the use of primary cultures for investigation of schwannoma tumorigenesis. To overcome the limited supply of primary cultures, the immortalized HEI193 VS cell line was generated by transduction with HPV E6 and E7 oncogenes. This oncogenic transduction introduced significant molecular and phenotypic alterations to the cells, which limit their use as a model for human schwannoma tumors. We therefore illustrate a simplified, reproducible protocol for culture of primary human VS cells. This easily mastered technique allows for molecular and cellular investigations that more accurately recapitulate the complexity of VS disease.

Entities:  

Mesh:

Year:  2014        PMID: 25079666      PMCID: PMC4220898          DOI: 10.3791/51093

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  18 in total

Review 1.  Neuropathology for the neuroradiologist: Antoni A and Antoni B tissue patterns.

Authors:  F J Wippold; M Lubner; R J Perrin; M Lämmle; A Perry
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-24       Impact factor: 3.825

2.  The behavior of acoustic neuroma in tissue culture.

Authors:  H Cravioto; R Lockwood
Journal:  Acta Neuropathol       Date:  1969-01-31       Impact factor: 17.088

3.  Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas.

Authors:  Abraham Jacob; Janet Oblinger; Matthew L Bush; Victoria Brendel; Griffin Santarelli; Abhik R Chaudhury; Samuel Kulp; Krista M D La Perle; Ching-Shih Chen; Long-Sheng Chang; D Bradley Welling
Journal:  Laryngoscope       Date:  2011-11-22       Impact factor: 3.325

Review 4.  Neurofibromatosis type 2.

Authors:  Gareth R Evans; Simon K W Lloyd; Richard T Ramsden
Journal:  Adv Otorhinolaryngol       Date:  2011-02-24

Review 5.  The molecular biology and novel treatments of vestibular schwannomas.

Authors:  Brendan Fong; Garni Barkhoudarian; Patrick Pezeshkian; Andrew T Parsa; Quinton Gopen; Isaac Yang
Journal:  J Neurosurg       Date:  2011-07-29       Impact factor: 5.115

6.  Primary cultures of human vestibular schwannoma: selective growth of schwannoma cells.

Authors:  Salil Nair; Hing Leung; Anne Collins; Richard Ramsden; Janet Wilson
Journal:  Otol Neurotol       Date:  2007-02       Impact factor: 2.311

Review 7.  A review of treatment modalities for vestibular schwannoma.

Authors:  Benjamin J Arthurs; Robert K Fairbanks; John J Demakas; Wayne T Lamoreaux; Neil A Giddings; Alexander R Mackay; Barton S Cooke; Ameer L Elaimy; Christopher M Lee
Journal:  Neurosurg Rev       Date:  2011-02-09       Impact factor: 3.042

8.  Short-term tissue culture observations of experimental primary and transplanted nervous system tumors.

Authors:  H D Mennel
Journal:  J Neuropathol Exp Neurol       Date:  1980-11       Impact factor: 3.685

9.  Genetic and epigenetic alterations of the NF2 gene in sporadic vestibular schwannomas.

Authors:  Jong Dae Lee; Tae Jun Kwon; Un-Kyung Kim; Won-Sang Lee
Journal:  PLoS One       Date:  2012-01-25       Impact factor: 3.240

Review 10.  Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II].

Authors:  D Gareth R Evans
Journal:  Genet Med       Date:  2009-09       Impact factor: 8.822

View more
  5 in total

1.  Generation of genomic deletions in mammalian cell lines via CRISPR/Cas9.

Authors:  Daniel E Bauer; Matthew C Canver; Stuart H Orkin
Journal:  J Vis Exp       Date:  2015-01-03       Impact factor: 1.355

2.  A Unified Methodological Framework for Vestibular Schwannoma Research.

Authors:  Lukas D Landegger; Jessica E Sagers; Sonam Dilwali; Takeshi Fujita; Mehmet I Sahin; Konstantina M Stankovic
Journal:  J Vis Exp       Date:  2017-06-20       Impact factor: 1.355

3.  Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.

Authors:  Jennifer Kersigo; Lintao Gu; Linjing Xu; Ning Pan; Sarath Vijayakuma; Timothy Jones; Seiji B Shibata; Bernd Fritzsch; Marlan R Hansen
Journal:  Laryngoscope       Date:  2020-05-21       Impact factor: 3.325

4.  Persistent Oxidative Stress in Vestibular Schwannomas After Stereotactic Radiation Therapy.

Authors:  Zachary N Robinett; Girish Bathla; Angela Wu; James Jason Clark; Zita A Sibenaller; Thomas Wilson; Patricia Kirby; Bryan G Allen; Marlan R Hansen
Journal:  Otol Neurotol       Date:  2018-10       Impact factor: 2.311

5.  Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients.

Authors:  Kimberly Laskie Ostrow; Katelyn Donaldson; Jaishri Blakeley; Allan Belzberg; Ahmet Hoke
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.